A Study of the Inflammatory Pathways Associated with Chronic Obstructive Pulmonary Disease Exacerbations

Study identifier:CD-RI-INDP-1048

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Exploratory Study of the Cellular Inflammatory Mechanisms Associated with Chronic Obstructive Pulmonary Disease Exacerbations

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

N/A

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

Study type

Observational

Age

40 Years - 85 Years

Date

Study Start Date: 01 Apr 2011

Primary Completion Date: 01 Jan 2012

Study Completion Date: 01 Feb 2012

Study design

Allocation: Not applicable
Endpoint Classification: -
Intervention Model: Not applicable
Masking: Not applicable
Primary Purpose: -

Verification:

Verified 01 Aug 2012 by MedImmune, LLC

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Dublin , Ireland, 15

Arms	Assigned Interventions
COPD subjects Adult male and female subjects with COPD	-

"There is no result for the study"

Documents available

Click here and search for drug information provided by the FDA.
Download
Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.
Download
Click here to find results for studies related to marketed products.
Download
Trial Results Summaries
Available here

Contacts

Contact

Sara Sandbach

clinicaltrialenquiries@medimmune.com

Investigators

Principal Investigator

Rene van der Merwe

MedImmune, Ltd.